I4337 2 mg (Terazosin Hydrochloride 2 mg)
Pill with imprint I4337 2 mg is White & Yellow, Capsule-shape and has been identified as Terazosin Hydrochloride 2 mg. It is supplied by Teva Pharmaceuticals USA.
Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for I4337 2 mg
Terazosin Hydrochloride
- Imprint
- I4337 2 mg
- Strength
- 2 mg
- Color
- White & Yellow
- Size
- 16.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antiadrenergic agents, peripherally acting
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- National Drug Code (NDC)
- 00093-4337
- Inactive Ingredients
-
corn starch,
crospovidone,
D&C Yellow No. 10,
aluminum oxide,
FD&C Blue No. 1,
FD&C Blue No. 2,
indigotindisulfonate sodium,
FD&C Red No. 40,
gelatin,
lactose monohydrate,
magnesium stearate,
propylene glycol,
shellac,
ferrosoferric oxide,
magnesium silicate,
titanium dioxide,
D&C Red No. 33
Note: Inactive ingredients may vary.
More about terazosin
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 42 Reviews
- Drug class: antiadrenergic agents, peripherally acting
- FDA Alerts (1)
Consumer resources
- Other brands
- Hytrin
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.